FDA Inspection 1181832 — Homeolab International Canada, Inc.
The FDA completed an inspection of Homeolab International Canada, Inc. on Sep 16, 2022 in Saint-Laurent. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 16, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Saint-Laurent (Canada)